Upsher-Smith Labs., Inc. v. La. Wholesale Drug Co.

570 U.S. 913, 133 S. Ct. 2849, 186 L. Ed. 2d 904, 81 U.S.L.W. 3697, 2013 WL 3155223, 2013 U.S. LEXIS 4861
CourtSupreme Court of the United States
DecidedJune 24, 2013
DocketNo. 12–265.
StatusPublished
Cited by13 cases

This text of 570 U.S. 913 (Upsher-Smith Labs., Inc. v. La. Wholesale Drug Co.) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Upsher-Smith Labs., Inc. v. La. Wholesale Drug Co., 570 U.S. 913, 133 S. Ct. 2849, 186 L. Ed. 2d 904, 81 U.S.L.W. 3697, 2013 WL 3155223, 2013 U.S. LEXIS 4861 (2013).

Opinion

Justice ALITO took no part in the consideration or decision of this petition.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Apotex, Inc. v. Cephalon, Inc.
321 F.R.D. 220 (E.D. Pennsylvania, 2017)
In Re: Loestrin 24 FE v.
First Circuit, 2016
American Sales Co. v. Warner Chilcott Co.
814 F.3d 538 (First Circuit, 2016)
King Drug Co. of Florence, Inc. v. Cephalon, Inc.
309 F.R.D. 195 (E.D. Pennsylvania, 2015)
In re Lipitor Antitrust Litigation
46 F. Supp. 3d 523 (D. New Jersey, 2014)
In re Nexium (Esomeprazole) Antitrust Litigation
297 F.R.D. 168 (D. Massachusetts, 2013)
In re Nexium
968 F. Supp. 2d 367 (D. Massachusetts, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
570 U.S. 913, 133 S. Ct. 2849, 186 L. Ed. 2d 904, 81 U.S.L.W. 3697, 2013 WL 3155223, 2013 U.S. LEXIS 4861, Counsel Stack Legal Research, https://law.counselstack.com/opinion/upsher-smith-labs-inc-v-la-wholesale-drug-co-scotus-2013.